To test this hypothesis, we took advantage of the mouse SCLC cell lines established from a CRISPR-derived Tp53, Rb1, Rbl2 (RPP) SCLC genetically engineered mouse model (21, 23). Here, TP53 is linked to small cell lung carcinoma.